相似文献
1
Strategies for advancing cancer nanomedicine.
Nat Mater. 2013 Nov;12(11):958-62. doi: 10.1038/nmat3792.
2
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
J Control Release. 2016 Dec 28;244(Pt A):108-121. doi: 10.1016/j.jconrel.2016.11.015. Epub 2016 Nov 18.
3
Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
AAPS PharmSciTech. 2020 May 14;21(4):132. doi: 10.1208/s12249-020-01691-3.
4
Combining Nanomedicine and Immunotherapy.
Acc Chem Res. 2019 Jun 18;52(6):1543-1554. doi: 10.1021/acs.accounts.9b00148. Epub 2019 May 23.
5
Overcoming the tumor microenvironment: the role of nanohyperthermia.
Nanomedicine (Lond). 2017 Jun;12(11):1213-1215. doi: 10.2217/nnm-2017-0096. Epub 2017 May 18.
6
Tumor Microenvironment-Enabled Nanotherapy.
Adv Healthc Mater. 2018 Apr;7(8):e1701156. doi: 10.1002/adhm.201701156. Epub 2017 Dec 28.
7
Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.
Nanomedicine. 2016 Feb;12(2):269-86. doi: 10.1016/j.nano.2015.10.020. Epub 2015 Dec 17.
8
Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Mar-Apr;8(2):208-22. doi: 10.1002/wnan.1358. Epub 2015 Jul 7.
9
Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
J Control Release. 2018 May 10;277:35-47. doi: 10.1016/j.jconrel.2018.03.012. Epub 2018 Mar 12.
10
Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment.
Med Res Rev. 2020 May;40(3):1084-1102. doi: 10.1002/med.21644. Epub 2019 Nov 11.
引用本文的文献
1
Non-invasive assessment for intratumoural distribution of interstitial fluid flow.
Magn Reson Lett. 2023 Mar 16;3(4):286-297. doi: 10.1016/j.mrl.2023.03.001. eCollection 2023 Nov.
2
PEGylation strategies for enhanced nanoparticle delivery to tumor associated immune cells.
bioRxiv. 2025 Jul 27:2025.07.23.666401. doi: 10.1101/2025.07.23.666401.
3
Nanotechnology for immuno-oncology.
Nat Cancer. 2025 Aug 7. doi: 10.1038/s43018-025-01025-x.
4
Unlocking Superior MFH Performance Below Hergt's Biological Safety Limit: SPION-Based Magnetic Nanoplatforms Deliver High Heating Efficiency at Low AMF.
Bioengineering (Basel). 2025 Jun 30;12(7):715. doi: 10.3390/bioengineering12070715.
5
A self-directed Trojanbot-enzymatic nanobot in neutrobot for active target therapy of glioblastoma.
Nat Commun. 2025 Jun 6;16(1):5263. doi: 10.1038/s41467-025-60422-z.
6
Targeting phosphatidylserine in tumor cell membranes with a zinc-containing molecule to efficiently combat tumor metastasis.
J Nanobiotechnology. 2025 May 20;23(1):363. doi: 10.1186/s12951-025-03418-7.
7
SCORT-Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo.
Adv Sci (Weinh). 2025 Jun;12(23):e2417605. doi: 10.1002/advs.202417605. Epub 2025 May 11.
8
Engineering Cup-Shaped Nanomotors for Promoting Cell Internalization and Synergistic Tumor Therapy.
Research (Wash D C). 2025 Apr 22;8:0623. doi: 10.34133/research.0623. eCollection 2025.
9
Nanotherapeutic strategies exploiting biological traits of cancer stem cells.
Bioact Mater. 2025 Apr 3;50:61-94. doi: 10.1016/j.bioactmat.2025.03.016. eCollection 2025 Aug.
10
Targeting Cancer Stemness Using Nanotechnology in a Holistic Approach: A Narrative Review.
Pharmaceutics. 2025 Feb 20;17(3):277. doi: 10.3390/pharmaceutics17030277.
本文引用的文献
1
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels.
Nat Commun. 2013;4:2516. doi: 10.1038/ncomms3516.
2
Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.
J Clin Oncol. 2013 Jun 10;31(17):2205-18. doi: 10.1200/JCO.2012.46.3653. Epub 2013 May 13.
3
Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles.
Science. 2013 Feb 22;339(6122):971-5. doi: 10.1126/science.1229568.
4
Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities.
Science. 2012 Nov 16;338(6109):903-10. doi: 10.1126/science.1226338.
5
Trastuzumab emtansine for HER2-positive advanced breast cancer.
N Engl J Med. 2012 Nov 8;367(19):1783-91. doi: 10.1056/NEJMoa1209124. Epub 2012 Oct 1.
6
Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors.
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15101-8. doi: 10.1073/pnas.1213353109. Epub 2012 Aug 29.
7
Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model.
Ann Biomed Eng. 2013 Jan;41(1):68-77. doi: 10.1007/s10439-012-0630-4. Epub 2012 Aug 2.
8
Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation.
Nano Lett. 2012 Jul 11;12(7):3369-77. doi: 10.1021/nl204175t. Epub 2012 Jun 11.
9
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner.
Nat Nanotechnol. 2012 Apr 8;7(6):383-8. doi: 10.1038/nnano.2012.45.
10
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer.
Gut. 2013 Jan;62(1):112-20. doi: 10.1136/gutjnl-2012-302529. Epub 2012 Mar 30.
Zotero 插件